Investments support advanced research & development and procurement of CBRN medical countermeasures (MCMs) to address national security threats.
CBRN MCM National Security Procurements
Invested in FY2023 CBRN MCMs
BARDA is the lead center within HHS for the advanced research & development (AR&D) as well as procurement of medical countermeasures (MCMs) to protect the American civilian population from CBRN threats. Ultimately, these MCMs are used to help the Nation prepare for, respond to, and recover from public health emergencies arising from naturally occurring and intentionally engineered threats. CBRN uses its AR&D authorities to help innovators develop promising candidate MCMs from preclinical development to clinical trials and manufacturing scale-up to FDA approval. CBRN leverages its Project BioShield (PBS) authorities to procure approved or approvable MCMs to save lives and protect Americans from 21st century health security threats.
Make Available at Least One Countermeasure for all CBRN Material Threats
The goal of AR&D funding is to build a sustainable MCM pipeline to prevent or treat illnesses and injuries caused by CBRN threats. AR&D funds support innovative products through all phases of the development pipeline, from discovery and preclinical research, to clinical trials needed to prove safety and efficacy, and manufacturing and regulatory approval needed to bring a product to market. CBRN also uses AR&D funding to develop and utilize preclinical models to study the illnesses and injuries caused by CBRN threats and the MCMs to treat those illnesses and injuries.
BARDA is investing in an array of medical countermeasures to treat or prevent illnesses and injuries caused by CBRN threats under the BARDA Broad Agency Announcement (BAA-18-100-SOL-00003).BARDA uses Project BioShield funding to support late-stage development, including post-marketing requirements and Phase IV clinical trials, and procurement of critical medical countermeasures, including vaccines and therapeutics, to prevent and treat CBRN threats. These MCMs are made available when a public health emergency, such as an anthrax attack or a nuclear detonation, occurs.
Check back soon for links to Requests for Proposals (RFP) for new efforts to be supported by Project BioShield funds.CBRN invests in innovative MCMs to treat or prevent the medical consequences that result from naturally occurring and intentionally engineered chemical, biological, radiological, and nuclear threats.
CBRN has a proven track record of developing life-saving medical countermeasures. We will continue to work with partners old and new to treat or prevent the medical consequences that result from CBRN threats.
Threat Area Filters
Impact Area Filters
The tools and resources you need as a first responder, planner, and healthcare provider to prepare your community to respond to a Chemical, Hazardous Materials and Nuclear and Radiological Emergencies
Guidance for health care providers about clinical diagnosis and treatment of radiation injury, guidance for the wider health care community, and tactical information for those without formal radiation medicine expertise. Available online or offline (with downloadable version in advance) to ensure availability during an event if the internet is not accessible. Be prepared and download this guidance today so your organization is ready to respond.
Learn MoreThe first minutes of a chemical incident is critical to a patient’s survival! Do you know what to do to save their life? CHEMM provides you tools and information needed for first responders, healthcare providers, and planners to save lives during a chemical incident. Available online or offline (with downloadable version in advance) to ensure availability during an event if the internet is not accessible
Learn More
